PRADOC: A multicentre randomized controlled trial to assess the efficiency of PRADO-IC, a nationwide pragmatic transition care management plan for hospitalized patients with heart failure in France - 16/01/25
, J.-P. Labarre 2, M. Galinier 3, P. Berdague 4, N. Erika 5, Q. Delbaere 6, M. Robin 6, E. Prunet 7, F. Leclercq 6, J.-L. Pasquie 8, L. Papinaud 9, G. Mercier 10, J.-E. Ricci 11, G. Cayla 12Abstract |
Introduction |
The PRADO-IC is a transition care programme designed to improve the coordination of care between hospital and home that was generalized in France in 2014. The PRADO-IC consists of an administrative assistant who visits patients during hospitalization to schedule follow-up visits.
Objective |
The aim of the present study was to evaluate the PRADO-IC programme based on the hypotheses provided by health authorities.
Method |
The PRADOC study is a multicentre controlled randomized open-label mixed-method trial of the transition programme PRADO-IC vs. usual management in patients hospitalized with heart failure (SOC group; NCT03396081).
Results |
A total of 404 patients were recruited between April 2018 and May 2021 (Fig. 1).
The mean patient age was 75 years (±12 years) in both groups. The two groups were well balanced regarding severity indices. At discharge, patients homogeneously received the recommended drugs. There was no difference between groups regarding hospitalizations for acute heart failure at 1 year, with 24.60% in the SOC group and 25.40% in the PRADO-IC group during the year following the index hospitalization [hazard ratio (HR)=1.04, 95% confidence interval (CI)=0.69–1.56; P=0.85] or cardio-vascular mortality (HR=0.67, 95% CI=0.34–1.31; P=0.24).
Conclusion |
The PRADO-IC has not significantly improved clinical outcomes, though a trend toward reduced cardiovascular mortality is evident. These results will help in understanding how transitional care programmes remain to be integrated in current patients’ pathways, including telemonitoring, and to better tailor individualized approaches.
Le texte complet de cet article est disponible en PDF.Plan
Vol 118 - N° 1S
P. S33 - janvier 2025 Retour au numéro
Article précédent
- Machine learning score using multiparametric assessment for death prediction in cardiac amyloidosis
- R. Mirailles, T. Pezel, M. Kharoubi, M. Nicol, A. Cohen Solal, P. Henry, D. Logeart, F. Beauvais, M. Baudet, T. Goncalves, E.S. Canuti, M. Le Maistre, S. Oghina, V. Tacher, E. Audureau, S. Toupin, T. Damy
- Prognostic outcomes in heart failure based on simple severity criteria: Insights from the French national healthcare coverage database
- G. Baudry, O. Pereira, F. Roubille, M. Villaceque, T. Damy, S. Schramm, K. Duarte, P. Tangre, N. Girerd
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?